Stocks Hitting 52-Week Highs

shares touched a new 52-week high of $25.65 after the company said a Phase Ib trial of its DX-2930 drug met safety goals and demonstrated statistically significant reductions in attack rates of hereditary angiodema, a rare disease.

shares gained 1.60% to reach a new 52-week high of $32.46. China Eastern's trailing-twelve-month revenue is $15.09 billion.

shares climbed 1.83% to reach a new 52-week high of $2.79. On Monday, Books-A-Million reported Q4 sales of $160.8M and adjusted EPS of $1.28.

shares jumped 7.76% to touch a new 52-week high of $21.80 after the company priced 1.52 million share common stock offering at $19.50 per share.